InvestorsHub Logo
Followers 0
Posts 813
Boards Moderated 0
Alias Born 07/25/2017

Re: None

Saturday, 08/12/2017 12:55:22 AM

Saturday, August 12, 2017 12:55:22 AM

Post# of 46519
10Q Suggests Dilution is coming

I am aware they own merimed stock but it doesn't appear as though the company is looking to sell it any time.

I would be expecting dilution – and please no attacks here is factual commentary from the 10Q


$86k in cash

Six months operating cash flow losses of $325k

Promissory notes in DEFAULT


"We issued promissory notes in the amount of $290,000 during the six months ended June 30, 2016. The promissory notes carry a 6% annual interest rate. All of the promissory notes have reached their maturity date and are currently in default. The holders of the promissory notes shall receive repayment in the full face amount of the note from the initial $750,000 the Company actually receives from the net proceeds of its patent infringement claim(s) or from the net proceeds of a public offering.



“the business up to the spin off continued to run in a severely diminished mode due to the lack of liquidity. Post spin off we still need to raise a sufficient amount of capital to provide the resources required that would enable us to continue running the business.



“The funds raised in our 2017 and 2016 financings were and will be used to enhance our patent portfolio, pay salaries to management and pay professional fees to our attorneys and auditors to prepare and file reports with the Securities and Exchange Commission. We hope to raise additional funds to be used for further developing our portfolio of patents and to document our technology in order to enforce our patents where there is infringement.”